A phase III multicentre, randomized, double-blind, parallel-group study of valdecoxib 40 mg vs. placebo in patients with multiple moderate or severe acute migraine headaches with and without aura. - Thomas,HM.; Kudrow,DB.; Ashford,E. (Cephalalgia, 2003)